Impact of cellular restriction gene (TRIM5α, BST‐2) polymorphisms on the acquisition of HIV‐1 and disease progression. (25th January 2018)

• Record Type: Journal Article
• Authors: Singh, HariOm; Samani, Dharmesh; Ghate, Manisha V.; Gangakhedkar, Raman R.
• Is Part Of: Journal of gene medicine. Volume 20:Number 2/3(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-01-25
• Subjects: AIDS restriction factor -- disease progression -- genetic predisposition -- HIV -- TRIM5α; Genetic transformation -- Periodicals; Gene Transfer -- Periodicals; Gene Therapy -- Periodicals; 616.042
• DOI: 10.1002/jgm.3004
• Languages: English
• ISSNs: 1099-498X

Abstract

Abstract: Background: TRIM5α and BST‐2 are cellular restriction factors affecting the HIV‐1 infection and its progression. Genetic variability in these genes alters the expression pattern. Hence, we aimed to examine the impact of the TRIM5 α (rs10838525, rs7127617 and rs904375) and BST2 (rs3217318 and rs71694748) polymorphisms on the acquisition of HIV‐1 and its progression. Methods: Genotyping of TRIM5α and BST‐2 polymorphisms was performed in a total of 153 HIV‐infected patients and 158 unrelated healthy individuals using a polymerase chain reaction‐restriction fragment length polymorphism method. Results: No significant differences were found in the genotype frequencies of TRIM5α polymorphisms between HIV patients and healthy controls. BST‐2 Δ19/i19 and i19/i19+ Δ19/i19 genotypes appeared more frequently in HIV patients compared to healthy controls (10.4% versus 7.0%, p = 0.20; 11.10% versus 7.6%, p = 0.16). The BST‐2 i19 allele was associated with the acquisition of HIV‐1 [odds ratio (OR) = 2.76, p = 0.030)]. TRIM5α haplotypes ATG and ACA elevated the risk, whereas haplotype ATA reduced the risk for the acquisition of HIV‐1 (OR = 1.92, p = 0.026; OR = 4.88, p = 0.016; OR = 0.31, p = 0.014). BST‐2 Δ19/i19 and i19/i19+ Δ19/i19 genotypes were more prevalent in patients with early HIV disease stage compared to healthy controls (15.9% versus 7.0%, p = 0.096; 15.9% versus 7.6%, p = 0.12). The prevalence of TRIM5α rs7127617 CC and BST‐2 Δ19/i19 genotypes was observed to be higher in alcohol‐using HIV patients compared to non‐users (27.8% versus 20.0%, p = 0.35, 22.2% versus 10.0%, p = 0.24). Conclusions: TRIM5α haplotypes and the BST‐2 i19 allele may significantly affect the modulation of HIV‐1 acquisition and its progression. TRIM5α rs7127617 CC and BST‐2 Δ19/i19 genotypes in alcohol‐using HIV patients elevated the risk of HIV disease progression.